Digital holographic microscopy (DHM) in medicine utilizes advanced optical technology to capture and analyze holographic information from biological specimens. Unsuch as traditional microscopy, DHM records both intensity and phase information, enabling three-dimensional imaging with nanometer-scale resolution. This non-invasive technique facilitates detailed examination of living cells and tissues, allowing for real-time monitoring and analysis. DHM's applications include cellular dynamics, pathology studies, and drug development, offering valuable insights for medical research and diagnostics.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-digital-holographic-microscopy-in-medical-market
Data Bridge Market Research analyses that North America Digital Holographic Microscopy in Medical Market which was USD 33.98 million in 2021 and is expected to reach USD 353.23 million by 2029, at a CAGR of 34.00% during the forecast period of 2022 to 2029. A conducive regulatory environment with well-defined frameworks and guidelines accelerates the acceptance and integration of digital holographic microscopy into medical research and diagnostics, fostering innovation and reliability in healthcare applications.
Key Findings of the Study
High usage of lensless digital holographic microscopy in medical is expected to drive the market's growth rate
The extensive utilization of lensless digital holographic microscopy in medicine is propelled by its compatibility with compact, affordable instruments ideal for microfluidic assessments and point-of-care disease detection. This lensless approach digitally reproduces small specimen images without traditional lenses, resulting in lighter, smaller, and cost-effective devices. The lensless imaging paradigm facilitates high-throughput and high-resolution imaging through portable and economical tools. Anticipated growth in the use of lensless digital holographic microscopy in medicine is expected to significantly drive the digital holographic microscopy market in the medical sector.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Label-Free Interferometric Technique and Quantitative Phase Image), Offering (Hardware and Software), Process Type (Digital Recording and Reconstruction), Configuration (Gabor Holography (Inline Holography), Image Plane Holography, Fresnel Holography, Fourier Holography, and Off-Axis Holography), Application (Quantitative Study of Cellular Dynamics, 3-D Imaging, Diabetics Diagnosis, Visualization of Drug-Induced Morphology Changes, Resolve Neuronal Network Activity and Others), End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Academic Medical Centers and Research Organizations)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
Lyncée Tec SA (Switzerland), Holoxica Ltd (U.K.), RealView Imaging Ltd (Israel), EON Reality (U.S.), Leia Inc. (U.S.), Geola (Lithuania), Holmarc Opto-Mechatronics Ltd. (India), Ovizio (Belgium), Realfiction (Sweden), ZEISS International (Germany), Jasper Display Corp.(U.S.), Trimos (Switzerland)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and pestle analysis.
|
Segment Analysis:
The North America digital holographic microscopy in medical market is segmented on the basis of type, offering, process type, configuration, application and end user.
- On the basis of type, the North America digital holographic microscopy in medical market is segmented into label-free interferometric technique and quantitative phase image
- On the basis of offering, the North America digital holographic microscopy in medical market is segmented into hardware and software
- On the basis of process type, the North America digital holographic microscopy in medical market is segmented into digital recording and reconstruction
- On the basis of configuration, the North America digital holographic microscopy in medical market is segmented into gabor holography (inline holography), image plane holography, fresnel holography, fourier holography, and off-axis holography
- On the basis of application, the North America digital holographic microscopy in medical market is segmented into quantitative study of cellular dynamics, 3-D imaging, diabetics diagnosis, visualization of drug-induced morphology changes, resolve neuronal network activity, and others
- On the basis of end user, the North America digital holographic microscopy in medical market is segmented into hospitals and clinics, pharmaceutical and biotechnological companies, and academic medical centers and research organizations
Major Players
Data Bridge Market Research recognizes the following companies as the major North America digital holographic microscopy in medical market players in North America digital holographic microscopy in medical market are Geola (Lithuania), Holmarc Opto-Mechatronics Ltd. (India), Ovizio (Belgium), Realfiction (Sweden), ZEISS International (Germany), Jasper Display Corp.(U.S.), Trimos (Switzerland)
Market Developments
- In January 2023, augmented reality innovator ThirdEye launched a fully integrated thermal solution to its smart glasses lineup. This enhancement seamlessly combines human hologram images with an integrated thermal camera feed. The integration empowers doctors with real-time visual data during remote consultations, enabling more precise diagnoses and treatment recommendations, thereby advancing the efficacy of medical services through cutting-edge technology
- In November 2022, GigXR and ANIMA RES launched an integrated suite of holographic real-time 3D (RT3D) organ simulation models. Designed for medical education, these models enable students to observe virtual organs in different disease stages, offering precise insights into organ function and disease progression. This innovative tool enhances medical education by providing a realistic and immersive learning experience for aspiring healthcare professionals
- In December 2020, HÜBNER Photonics launched the Cobolt 05-iE, a fully integrated version of potent single-frequency lasers spanning 457 nm – 1064 nm. This addition to their product line enhances laser options for diverse applications, showcasing the company's commitment to advancing compact and powerful solutions across a broad wavelength spectrum for scientific and industrial uses
- In October 2020, Lyncee Tec expanded its product line with the launch of the EVOLUTIVE DHM T series microscope. This new model is designed to delve into physiopathological processes and assess cell health. The launch strengthens Lyncee Tec's digital holographic microscope portfolio, showcasing the company's commitment to advancing capabilities in exploring cellular dynamics and contributing to advancements in medical research and diagnostics
- In July 2020, Intelligent Imaging Innovations and Forth Dimension Displays (ForthDD), a Kopin Corporation subsidiary, extended their collaboration by launching 3i's Cleared Tissue LightSheet (CTLS). This product launch marked a significant expansion of 3i's product line, enhancing their offerings in the field of advanced imaging technologies and further solidifying the collaboration between Intelligent Imaging Innovations and Forth Dimension Displays
Regional Analysis
Geographically, the countries covered in the North America digital holographic microscopy in medical market report are U.S., Canada and Mexico in North America.
As per Data Bridge Market Research analysis:
U.S. is the dominant country in North America digital holographic microscopy in medical market during the forecast period 2022-2029
U.S. dominates the North American digital holographic microscopy in medical market for quantitative phase imaging due to increased adoption of advanced research technologies. The region's prominence stems from a proactive embrace of cutting-edge tools, particularly holographic microscopy, accentuating its leadership in advancing medical research and diagnostics. The growing prevalence of these technologies underscores the U.S.'s pivotal role in shaping the quantitative phase imaging landscape within the healthcare sector.
Mexico is estimated to be the fastest growing country in North America digital holographic microscopy in medical market during the forecast period 2022-2029
Mexico is expected to dominate the North American digital holographic microscopy in medical market, attributing its leadership to the affordability of the technology and consistent technological advancements within the country. The lower cost of digital holographic microscopy, coupled with ongoing innovations, positions Mexico as a key player, driving market growth and accessibility in medical research and diagnostics.
For more detailed information about the North America digital holographic microscopy in medical market report, click here – https://www.databridgemarketresearch.com/reports/north-america-digital-holographic-microscopy-in-medical-market
